CDKN2A and neoplasm: The tumor showed EGFR C797S, T790M, exon 19 deletion (T751_I759>N), CDK4 amplification, MDM2 amplification, CDKN2A/B loss, MTAP loss, low MSI, low TMB and negative PD-L1.